First Light Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

First Light Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.52M	Sell	85,765 -1,416	-2%	-$128K	0.58%	31
2026 Q1	$7.58M	Sell	87,181 -208,663	-71%	-$20.3M	0.68%	35
2025 Q4	$31.7M	Buy	295,844 +115,360	+64%	+$12.2M	2.42%	15
2025 Q3	$18.2M	Buy	+180,484	New	+$16.8M	1.72%	21

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First Light Asset Management's RYTM Position: Q2 2026 in Review

First Light Asset Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 1.6% in Q2 2026, selling an estimated $128K and leaving 85,765 shares worth $9.52M. The position accounts for 0.58% of the portfolio, ranked #31.

First Light Asset Management first reported a position in RYTM in Q3 2025 and has held it in 4 quarters since. The position peaked at $31.7M in Q4 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

First Light Asset Management held 85,765 shares of Rhythm Pharmaceuticals worth $9.52M as of Q2 2026.
First Light Asset Management sold 1,416 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $128K.
Rhythm Pharmaceuticals made up 0.58% of First Light Asset Management's portfolio in Q2 2026, its #31 holding.
First Light Asset Management first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
First Light Asset Management's Rhythm Pharmaceuticals position peaked at $31.7M in Q4 2025.
304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.